What is the appropriate initial evaluation and management for a patient presenting with hand swelling?

Initial Evaluation and Management of Hand Swelling

Immediate Clinical Determination: Unilateral vs. Bilateral

The first critical step is determining whether hand swelling is unilateral or bilateral, as this fundamentally changes your diagnostic approach and urgency. 1, 2

• Unilateral hand swelling indicates an obstructive process (venous thrombosis, infection, trauma) requiring urgent duplex ultrasound within hours. 2, 3
• Bilateral hand swelling suggests systemic inflammatory, rheumatologic, or metabolic causes and is less emergent but requires systematic evaluation. 1, 3

---

For Unilateral Hand Swelling

Immediate Actions

• Order duplex ultrasound of the upper extremity urgently (sensitivity/specificity >80% for upper extremity DVT), as delay risks pulmonary embolism. 2, 3
• Obtain plain radiographs in minimum 3 views (PA, lateral, oblique) to exclude fracture, foreign body, soft tissue gas, bone destruction, or periosteal reaction. 2, 3
• Remove all constricting jewelry immediately to prevent vascular compromise as swelling progresses. 1

Laboratory Workup

• Order ESR and CRP to quantify inflammation. 3
• Obtain CBC with differential to identify infection, anemia of chronic disease, or thrombocytosis. 3
• If infection is suspected based on erythema, warmth, and acute onset, obtain cultures via image-guided aspiration before starting broad-spectrum antibiotics. 2, 4

Management Based on Findings

• If UEDVT is confirmed, initiate therapeutic anticoagulation immediately following standard DVT protocols with minimum 3-month duration for axillary or more proximal involvement. 2
• If infection is identified, start broad-spectrum antibiotics after cultures are obtained. 2
• Reassess within 48-72 hours if diagnosis remains uncertain or symptoms progress. 2, 3

---

For Bilateral Hand Swelling

Clinical Examination Priorities

Systematically examine joint distribution focusing on symmetric involvement of metacarpophalangeal (MCP), proximal interphalangeal (PIP), and distal interphalangeal (DIP) joints to differentiate inflammatory arthritis from osteoarthritis. 1

• True synovitis is identified by soft-tissue swelling not attributable to trauma or bony enlargements (Heberden's nodes), particularly when bilateral in MCP or PIP joints. 5, 1
• Perform a positive "squeeze test" across MCP and metatarsophalangeal joints—pain suggests inflammatory arthritis. 5
• Assess for morning stiffness >30 minutes duration, which indicates inflammatory disease rather than mechanical causes. 5, 1

Skin and Musculoskeletal Examination

• Inspect for psoriatic plaques (elbows, knees, scalp, genital area), nail changes (pitting, onycholysis), and sausage-shaped digits (dactylitis), as these strongly suggest psoriatic arthritis. 1
• Check for enthesitis at Achilles and plantar fascia insertions. 1
• Inflammatory DIP swelling points toward psoriatic arthritis, whereas bony spur formation indicates osteoarthritis. 1

Laboratory Workup

• Order ESR and CRP as objective markers of systemic inflammation. 1, 3
• Obtain CBC, urinalysis, transaminases, and antinuclear antibodies to exclude other diseases. 5
• Do not rely on rheumatoid factor alone for diagnosis, as it can be elevated in hepatitis C and other conditions. 1

Imaging When Clinical Examination is Equivocal

• Musculoskeletal ultrasound with power Doppler is appropriate for detecting synovitis, joint effusion, and tenosynovitis when clinical examination is uncertain. 1, 3
• MRI of bilateral hands (including PIP joints) detects synovitis, bone marrow edema, and tenosynovitis that correlate with symptoms when inflammatory arthritis is suspected but not confirmed. 1

---

Referral and Treatment Initiation

Rheumatology Referral Timing

Patients presenting with arthritis of more than one joint should be referred to and seen by a rheumatologist within 6 weeks of symptom onset. 5, 1

• Earlier treatment initiation in inflammatory arthritis improves long-term outcomes; delayed treatment is associated with radiographic damage in 7-47% of psoriatic arthritis patients within 2 years. 1

Disease-Modifying Therapy

• Do not start disease-modifying antirheumatic drugs (DMARDs) empirically; confirm diagnosis with rheumatology consultation before initiating targeted therapy. 1
• When inflammatory arthritis is confirmed, early DMARD initiation (methotrexate 25 mg orally once weekly with daily 1 mg folic acid) prevents irreversible joint damage. 1
• For psoriatic arthritis refractory to methotrexate, TNF-α inhibitors (adalimumab, etanercept, infliximab) are effective in relieving symptoms and preventing structural damage. 1

Symptomatic Treatment While Awaiting Specialist

• NSAIDs may be appropriate for symptom control while awaiting rheumatology evaluation. 1

---

Monitoring and Follow-Up

• Treatment response should be monitored using ACR20 criteria, requiring ≥20% improvement in tender/swollen joint counts plus ≥20% improvement in three of five additional domains (patient pain, global assessment, acute-phase reactants). 1
• Perform serial rheumatologic examinations with inflammatory markers every 4-6 weeks after treatment initiation. 3
• Schedule formal re-evaluation at 6 weeks if edema persists without clear etiology to detect evolving pathology. 1, 2

---

Critical Pitfalls to Avoid

• Do not dismiss bilateral hand swelling as benign edema without thorough evaluation for inflammatory arthritis; early identification prevents irreversible joint damage. 1
• Do not delay duplex ultrasound in unilateral swelling, as upper extremity DVT can cause pulmonary embolism requiring immediate anticoagulation. 2, 3
• Do not misinterpret brief morning stiffness (minutes) limited to DIP joints as inflammatory arthritis; prolonged stiffness (>30 minutes) with soft-tissue swelling is characteristic of inflammatory disease. 1
• Do not overlook psoriatic arthritis in patients lacking overt skin disease, as severe arthritis can occur with minimal cutaneous manifestations. 1
• Do not confuse bilateral with unilateral swelling: bilateral presentation does not require urgent vascular imaging unless clinical features suggest superior vena cava syndrome or bilateral upper extremity DVT. 1